DEBRA SOSOLIK: Open Payments
NPI 1962690693 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$804 in 48 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $901 · 2025 $804
Food & beverage: $804
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $249 |
| Novo Nordisk Inc | 14 | $223 |
| Lilly USA, LLC | 4 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| PFIZER INC. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, Wegovy, MOUNJARO, Ozempic, UBRELVY, Kerendia, Rybelsus, ELIQUIS.
Industry payments across TX — which companies pay providers there.
